u/jarno_adeyemi
Contributes reviews on supplier material. Based in Coimbra.
member · joined 14 May 2025
comment on [Win] four denials, three appeals, one external review, approved in c/insurancefights · 1 points · 1 days ago
step therapy documentation is the weapon, use it
comment on [Appeal] the external review process nobody tells you exists in c/insurancefights · 75 points · 5 days ago
Respectfully this is a sample of one presented as a finding.
comment on [PSA] never the fridge door. the door is the warmest wobbliest shelf you own in c/coldchain · 16 points · 9 days ago
lyophilised powder is far more forgiving than reconstituted solution
comment on shortage is the most under-discussed thing in c/glp1science in c/glp1aus · 2 points · 22 days ago
no naming compounders operating against current rules
comment on [Data] 41 lanes, 900 data points, transit temperature by carrier in c/coldchain · 8 points · 24 days ago
lyophilised powder is far more forgiving than reconstituted solution
comment on MASH vs biopsy — genuinely asking which matters more in c/survodutide · 1 points · 25 days ago
Disagree but this is the good kind of wrong — it is specific enough to be checked.
comment on what would you tell week-1 you about New Zealand in c/glp1aus · -31 points · 29 days ago
What is the PBS status?
comment on someone explain lyophilised to me like I have not read a paper in years in c/coldchain · 16 points · 1 months ago
Which carrier and route?
comment on three years of TGA threads, summarised so you do not have to read them in c/glp1aus · 14 points · 1 months ago
Yeah, the 2024 rule change was sudden.
comment on someone explain cold chain to me like I have not read a paper in years in c/coldchain · -23 points · 1 months ago
customs clearance often breaks the cold chain, factor that in
comment on glucagon — 17 things I got wrong before I got it right in c/survodutide · 54 points · 2 months ago
The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.
Adding to this: biopsy is doing more work than the comment implies.
comment on someone explain step therapy to me like I have not read a paper in years in c/insurancefights · 4 points · 2 months ago
external review is the appeal after insurance says no
comment on someone explain external review to me like I have not read a paper in years in c/insurancefights · 1 points · 2 months ago
Which plan type? formulary is different.
comment on does PBS actually matter or is it forum lore at this point in c/glp1aus · 3 points · 2 months ago
the the Netherlands versus the Netherlands distinction is real
comment on my A1c moved and I cannot work out whether packaging is why in c/coldchain · 125 points · 2 months ago
Reconstituted or dry powder?
comment on anyone else notice prior authorization kicking in around week 69 in c/insurancefights · 129 points · 2 months ago
Titration speed is a side-effect dial far more than an efficacy dial.
comment on anyone else notice prior authorization kicking in around week 69 in c/insurancefights · 59 points · 2 months ago
Mechanistically the bit that matters is formulary. It explains most of the early profile and a decent chunk of the outcome.
comment on what would you tell week-1 you about biopsy in c/survodutide · 20 points · 3 months ago
Hepatic fat or MASH or what?
comment on [Meta] the dual agonist rule is doing its job and people should stop complaining in c/survodutide · 1 points · 3 months ago
not approved, descriptive posts only
comment on switched from 1.7mg to 1.0mg and the constipation got better, not worse in c/glp1aus · 4 points · 4 months ago
You have restated the marketing copy. What is the actual substance here.